[ Special series on 150Q ]

doi: 10.1186/s40880-017-0210-y

The 150 most important questions in cancer research and clinical oncology series: Questions 25–30

Chinese Journal of Cancer

Chinese Journal of Cancer

[Abstract] To accelerate our endeavors to overcome cancer, Chinese Journal of Cancer has launched a program of publishing 150 most important questions in cancer research and clinical oncology. In this article, 6 more questions are presented as followed. Question 25: Does imprinting of immune responses to infections early in life predict future risk of childhood and adult cancers? Question 26: How to induce homogeneous tumor antigen expression in a heterogeneous tumor mass to enhance the efficacy of cancer immunotherapy? Question 27: Could we enhance the therapeutic effects of immunotherapy by targeting multiple tumor antigens simultaneously or sequentially? Question 28: Can immuno-targeting to cytokines halt cancer metastasis? Question 29: How can we dynamically and less-invasively monitor the activity of CD8+ T killer cells at tumor sites and draining lymph nodes? Question 30: How can the immune system destroy the niches for cancer initiation?

Chinese Journal of Cancer 2017, Volume: 36, Issue 5

[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)
[Google Scholar]

[ More articles of the special series on 150Q ]


Cite this article

Chinese Journal of Cancer. The 150 most important questions in cancer research and clinical oncology series: Questions 25–30. Chin J Cancer. 2017, 36:42. doi:10.1186/s40880-017-0210-y


Export citations

EndNote